For patients with endometrial cancer that has progressed on carboplatin and paclitaxel, what is the median progression-free survival when treated with monotherapy?
For patients with endometrial cancer that has progressed on carboplatin and paclitaxel, what is the median progression-free survival when treated with monotherapy?